// App-Quantinova.ai

: A comparison of pirfenidone versus nintedanib for the management of idiopathic pulmonary fibrosis

Researchers

Presenter

  • Marium Naqvi

Principal Investigators

  • Grainne D'Ancona

  • Alex West

Medical Centers

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

Biomarkers

  • N/A

Drug/Treatment

  • Pirfenidone

  • Nintedanib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved